The U.S. Food and Drug Administration has cleared a new artificial intelligence solution to help physicians incidentally detect patients’ risk of heard disease via commonly ordered CT scans.
HealthCCSng is the eighth FDA-cleared product from Israel-based Zebra Medical Vision, which previously scored regulatory approval in Europe. The AI tool works by analyzing non-gated computed tomography images, helping to quantify coronary artery calcium and separate patients into three different risk categories.
Cardiovascular disease is one of the leading causes of death worldwide, Zebra Medical noted Monday. Yet upward of 50% of patients don’t know they have CVD until after that first heart attack. The firm hopes to help clinicians catch heart concerns earlier, noting that patients in the highest coronary artery calcium scoring categories are 20 times likelier to suffer a cardiac event. However, gated CAC scans can prove costly and are often not covered by insurance.
Fellow Israel-based imaging firm Nanox recently revealed plans to acquire Zebra Medical Vision for $200 million and touted the FDA clearance in its own Sept. 27 announcement.
Related Cardiac CT and Calcium Scoring Content:
VIDEO: Current guidelines for the use of CT calcium scoring in preventive cardiology
VIDEO: Use of CT to assess coronary plaques — Interview with Leslee Shaw, PhD
Cardiac CT soft plaque assessment my offer paradigm shift for coronary disease screening.
VIDEO: Top 6 takeaways from the Society of Cardiovascular CT 2022 meeting — interview with Eric Williamson, MD
New CAD-RADS 2.0 reporting for coronary CTA offers patient management recommendations
VIDEO: The new role of cardiac CT under the 2021 chest pain evaluation guidelines — Interview with Eric Williamson, MD
New AI software a low-cost, efficient option for coronary artery calcium scoring
CAC scores help predict TAVR mortality
AI approach may lead to ‘on the fly’ risk scoring for heart attacks
New deep learning study brings automated CAC scoring ‘one step closer to clinical translation’
VIDEO: Office-based cardiac CT and FFR-CT offer a new business model
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.